• Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Analysts

    المصدر: Buzz FX / 06 فبراير 2025 04:56:09   America/New_York


    Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat February 6, 2025 Share Link copied to clipboard. Esperion Therapeutics, Inc.
    Read more...
شارك على،